← Evidence map

ArticleBlood advances2024

Tyrosine kinase inhibitor for CML: all the same?

Lukas Veltmaat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 39392647